-
Continue reading →: ALPHA-1062: A Promising New Treatment for Mild Traumatic Brain Injury in Veterans
For too many veterans, echoes of the battlefield linger long after deployment—not only in memory, but in the form of mild traumatic brain injuries (mTBI) caused by repetitive blast exposure. These “invisible wounds” can manifest as persistent physical, cognitive, and emotional symptoms, casting a shadow over daily life. But new…
-
Continue reading →: Beyond the Brain: How Inflammation and Body-Brain Communication Shape Depression—and the Next Generation of Treatments
We’ve come a long way since the days when philosophers saw the mind and body as wholly separate. Today, neuroscience and psychiatry increasingly emphasize what many with PTSD, depression, and anxiety already know: our mental states and physical health are inseparable, engaged in a dynamic, sometimes tumultuous, conversation. A comprehensive…
-
Continue reading →: From Mushrooms to Mind: Can Psilocybin Retreats Heal Veterans with Traumatic Brain Injury?
There has been a lot of hype around psychedelics for treating PTSD, anxiety, and depression. However, few studies have yet addressed the injury that many veterans are starting to think initiated these disorders—traumatic brain injury. A provocative new study provisionally accepted in Frontiers in Psychiatry suggests that well-structured psilocybin retreats may offer…
-
Continue reading →: Traumatic Brain Injury Treatments: A Hopeful Horizon in Neurotherapeutics
Traumatic brain injury (TBI) continues to be a significant challenge for millions worldwide, particularly military veterans for whom head trauma is a common hazard. But there’s reason for cautious optimism: a recent overview of the TBI drug development pipeline, “Traumatic Brain Injury Pipeline Insight 2025” from DelveInsight, paints a rapidly…
-
Continue reading →: New Mexico Considers Medical ‘Magic Mushrooms’ for PTSD and Depression
Legislative momentum behind Senate Bill 219, which proposes legalizing therapeutic psilocybin for conditions like PTSD and severe depression, is picking up speed. It’s a striking signal of how the conversation around mental health—and what counts as a legitimate tool for healing—is rapidly evolving. Why Psilocybin, and Why Now? Historically, options…
-
Continue reading →: Reading the Brain: How MDMA Affects Threat Circuits—and What This Means for Personalized PTSD Treatment
For many living with posttraumatic stress disorder (PTSD) or anxiety, new medications like MDMA (“ecstasy”) represent a glimmer of hope. But while clinical trials with MDMA-assisted therapy show promise, not everyone may benefit equally—and until recently, it wasn’t clear how to predict who would. A new randomized clinical trial from…
-
Continue reading →: Psilocybin Inches Forward: What Compass Pathways’ Phase III Data Means for Depression—and for Veterans
A new chapter in depression treatment may be underway—and you might’ve missed the headlines. Compass Pathways, a biotech company exploring the therapeutic potential of psychedelics, just released promising results from a Phase III clinical trial of COMP360, their synthetic psilocybin formulation, in people with treatment-resistant depression. For veterans and others…
-
Continue reading →: Can Boosting Self-Compassion Unlock Recovery from PTSD? New Research Highlights Role of MDMA-Assisted Therapy
For millions affected by posttraumatic stress disorder (PTSD)—including a large number of military veterans—finding hope and healing can feel like an uphill battle. Traditional treatments, while helpful for some, often fall short, leaving individuals grappling not only with persistent traumatic memories but also with feelings of shame, self-blame, and isolation.…
-
Continue reading →: What is a Clinical Trial?
Every breakthrough treatment starts long before it reaches the pharmacy. Before a single dose is given to a human being, researchers go through years of development, safety testing, and strict regulation. At the heart of this process is the clinical trial — the final step before a new therapy can…
Welcome to TrialFind Insights
Explore the frontlines of the mental health revolution—psychedelics, neuroscience, and the clinical trials pioneering the new era of mental health treatment.
- About Clinical Trials (1)
- Anxiety (0)
- Depression (1)
- News (1)
- Psychedelics (6)
- DMT (1)
- Ketamine (1)
- MDMA (2)
- Psilocybin (2)
- PTSD (0)
- Traumatic Brain Injury (3)
Join the Movement!
Stay updated with our free newsletter
TrialFind 